Aim: The aim of this study was to assess the factors which influence the care pathway after discharge from an acute palliative supportive care unit (APSCU).
A dvanced cancer patients develop a relevant symptom burden during the course of disease, requiring experience in palliative care. In most countries palliative care is commonly provided at home or in hospice. 1 Regrettably, palliative care is started late, as most of these patients are followed by palliative care teams in the last weeks of life. Moreover, they are often hospitalized and are receiving chemotherapy in the last month of life. 2 It has been reported that the interval between palliative care referral and death was <2 months. 3 In the last years it has been suggested that palliative care should be started early to support the patient during their therapeutic pathway, providing not only an adequate symptom control but also elements in the decision-making process, including discontinuation of active treatment and the appropriate choice of setting for a more specialized treatment, independently of the expected survival. Acute palliative/supportive care units (APSCUs) are inpatient units in oncological departments specialized in the treatment of complex physical and psychological symptoms. 1 Several studies have reported the positive outcomes of ASPCUs, including not only the capacity to support the crises during the active treatment, in a concept of simultaneous care, or to manage pain and symptoms, but also to redirect the therapeutic trajectory, facilitating the transition to palliative care. [4] [5] [6] [7] [8] When a patient is discharged from an ASPCU, he can continue some oncologic treatment or not, or can be referred to specialistic palliative care, particularly when he is considered to be unfit for a further oncologic treatment. However, factors influencing dispositions at discharge from a APSCU are lacking. The aim of this study was to assess the factors which influence the care pathway, including treatment and setting, after discharge from an APSCU with peculiar characteristics established about 20 years ago.
METHODS
This is a secondary analysis of a study assessing the influence of an APSCU on the therapeutic trajectory of oncological patients in a comprehensive cancer. 4 Patients' demographics, including age, sex, primary diagnosis, marital status, and educational level were collected. Karnofsky status and principal reason for admission, including pain or opioid-related problems, toxicity from chemotherapy, symptom control, reevaluation, or end of life issues, were recorded. The kind of admission, unplanned or not, or readmission was also recorded. Data regarding the caregiver, considered as a person who spent at least 4 hours per day with the patient, were recorded, as well as awareness of prognosis by semistructured interviews (complete, partial, absent).
Data on chemotherapy in the last 30 days, or other anticancer treatments (radiotherapy, surgery, target therapy, hormonal therapy, and so on), whether patients were on/off treatment or uncertain (that is the gray area of patients in which a definitive decision was not taken and postponed), the previous care setting, including home, hospital unit, day-hospital, or other hospitals, and who referred the patient to the unit, including home palliative care physicians, oncologists, other units, other hospitals, or general practitioner were also recorded. Analgesic drugs and their doses at admission and discharge were recorded. Hospital staying was also recorded. The following tools have been used: (a) The Edmonton Symptom Assessment Scale (ESAS) at admission and at time of discharge (or the day before death) (TD). ESAS is a self-reported tool assessing the intensity of most common psychological and physical symptoms on a 0 to 10 numerical scale. 9 It is a valid and reliable tool for assessing the overall symptom burden, and has been found to be sensible to changes produced by a treatment 10 ; (b) a screening test for history of alcohol dependence (CAGE: cut down, annoy, guilt, eye-opener). CAGE score has a sensitivity > 90% and specificity > 95% to detect alcoholism. 11 Patients with alcohol problems express more symptom distress and are more likely to have a history of smoking or illegal use of drugs 12 ; (c) the Memorial delirium Assessment Scale (MDAS), to assess patients' cognitive status. MDAS is a validated tool to quantify the intensity of delirium, 13 and has a relevant influence on symptom expression. 14 At time of discharge, the subsequent referral to other care settings (death, home, home care, hospice, oncology), and the pathway of proposed oncologic treatment were collected (on/ off, uncertain).
Statistical Analysis
Statistical analysis of quantitative and qualitative data, including descriptive statistics, was performed for all items. Continuous data are expressed as mean ± SD, unless otherwise specified. Differences between groups were assessed by χ 2 test or Fisher exact test, as needed for categorical variables, and by the independent Student t test for continuous parameters. The univariate analysis of variance was performed for parametric variables, and post hoc analysis with the Tukey test was used to determine whether there were pairwise intragroup differences. The variables significantly related to patient groups were analyzed in multinomial logistic regression model to examine the correlation between patient characteristics (independent variables), and patient groups (dependent variable). Any missing data regarding clinical variables (< 2%) were excluded from statistical analysis. Data were analyzed by IBM SPSS Software 22 version (IBM Corp., Armonk, NY). All P-values were 2-sided and P < 0.05 was considered statistically significant.
RESULTS
Three-hundred-fourteen consecutive cancer patients admitted to the APSCU were surveyed. For the different parameters taken into consideration, data were missed for <0% of patients (range, 0 to 20 patients). The characteristics of patients, stage of disease, kind of admission (urgent, readmission, etc.), information regarding people living with the patients, the presence of a caregiver, educational level, indications for admission, active treatments in the last 30 days, and patients' and caregivers' awareness of disease, are presented in Table 1 . Most admissions were planned, although a consistent number of patients were admitted on emergency (generally from the oncological day-hospital) or transferred from other hospital units. The mean hospital stay was 6.9 days (SD, 6.3). Twelve patients (3.8%) died in the unit. Data regarding the clinical pathways suggested at discharge from the unit, including how the patient was considered for treatment purposes (on/off, or uncertain), and the referral setting, are presented in Table 2 .
Discharge Care Pathway (On-Off-Uncertain)
In the univariate analysis low Karnofsky level (P < 0.0005), primary tumor (breast, P = 0.028), the presence of the caregiver (P = 0.004), less awareness of disease (P = 0.001), indications for admission (toxicity due to anticancer therapies, P = 0.019, other symptoms, P = 0.006, and end of life care P = 0.002), anticancer treatment in the last 30 days (0.001), referral setting (home care, P = 0.004), MDAS at T0 and MDAS at TD (0.001 and <0.0005, respectively), weakness at TD (P < 0.0005), depression at TD (P < 0.0005), drowsiness at TD (P = 0.004), appetite at T0 and TD (P = 0.030 and 0.009, respectively), poor well-being at TD (P = 0.003), global ESAS at TD (P = 0.016), hospital staying (P = 0.012), and discharge settings (home care, P < 0.0005), were associated with the decision to definitely stop oncological treatments at discharge (off therapy). Age, sex, education, stage of disease, CAGEpositivity, smoking habits, the kind of admission (planned or not, readmission), amount of opioid rugs (OME), did not influence the discharge therapeutic pathway.
The multivariate regression analysis regarding the treatment pathway (on-off-uncertain) is showed in Table 3 . Being "on-therapy" was independently associated with a lack of caregiver, home discharge, and shorter hospital admission, in comparison with off-treatment. In comparison with "uncertain" group, "on-treatment" was independently associated less admission for other symptoms, shorter hospital admission, discharge at home, and better well-being.
Discharge Setting
In the univariate analysis younger age (P = 0.009), higher Karnofsky level (P < 0.0005), stage of disease (no metastatic disease, P = 0.038), patient awareness (P < 0.0005), admission for uncontrolled pain (P = 0.011), referral setting (home, P < 0.0005), lower MDAS at T0 and TD (P = 0.007 and 0.001, respectively), on-treatment (P < 0.0005), no transfer from other units, P = 0.012), higher pain intensity at T0 (P < 0.0005), lower values of weakness (P < 0.0005), nausea (P = 0.004), depression (P < 0.0005), anxiety (P = 0.002), drowsiness (P < 0.0005), dyspnea (P = 0.030), insomnia (P = 0.004), appetite (P = 0.001), poor well-being (P < 0.0005), and global ESAS at TD (P < 0.0005) were associated with home discharge. The multivariate regression analysis is showed in Table 4 (discharge at home vs. home care, hospice or other). The only parameter independently associated with discharge home was "on-therapy." DISCUSSION APSCU serves a very heterogenous population with different characteristics, in terms of stage of disease ongoing treatments, and reasons for admission, covering a broad range of cancer patients, just from time of diagnosis until the end of life. Thus, many patients are still receiving and possibly will continue anticancer therapies, have a short hospital staying, and are unlikely to die in hospital. Differently from what it was reported in hospitals in United States where half of them provide palliative care services, 15 in most European countries, particularly Italy, most hospitals do not offer such opportunities, as palliative care is available as home care and hospice care services only, mainly not linked with the oncological setting, and accepting patients with a short survival in the last weeks of life. 16 Instead, an early palliative care intervention may have more beneficial effects on quality of life and symptom intensity among patients with advanced cancer than among those given usual/standard cancer care alone, and may increase use of approach-oriented coping, which was associated with higher quality of life and reduced depressive symptoms. 17 This study provided a series of data influencing decisionmaking process at discharge from an APSCU, regarding either the oncological treatment and the care setting. In comparison to patients considered off-therapy, patients considered to benefit from continuing anticancer treatment (on) were more likely to do not have a caregiver, according to the definition adopted in this study, to be discharged home without specialized home care, and to have a shorter hospitalization. When compared with the gray area of patients defined "uncertain," in which a definitive decision was not taken and postponed, patients "on-treatment" were more likely to have a shorter admission, to be discharged home, to have less admission for other symptoms, and a better poor well-being at discharge. Of interest, many other parameters taken into consideration in this study, including age, sex, education, stage of disease, CAGEpositivity, smoking habits, the kind of admission (planned or not, readmission), amount of opioid rugs (OME), did not influence the discharge disposition. The various variables examined did non influence the setting discharge, as the only variable associated with home discharge (without specialized home care service), was "on-therapy." Conversely, off-therapy patients were more likely to be discharged to palliative home care or hospice care services. This finding is consistent with an appropriate selection of patients after being discharged by an APSCU, that works as a bridge between active treatment and supportive/palliative care, according the concept of early and simultaneous care. The therapeutic and settings pathways support the need of specialized beds in an oncological department, where it is possible reevaluate patients and provide the right direction, other than controlling symptoms.
Available literature regarding discharge disposition after admission to an APSCU is poor. In Italy almost all inpatients palliative care units are represented by hospices, where survival is short (about 18 d) and almost all patients die. From these data, it appears that hospice admission is only one way for end of life treatments. Thus, patients admitted to hospice receive specialized palliative care only for 2 to 3 weeks before death, implying an inacceptable timing for patients with several problems presumed to be present early during the course of disease. 2 In a pioneer study, 59 and 41 patients discharged from an acute palliative care were transferred home and to hospice, respectively. Younger patients, a better functional status, being married, and with a better cognitive status, evaluated with MiniMental State Examination, were more likely to be transferred home. However, data regarding the trajectory of oncological treatments was unavailable. 18 In a more recent study, patients admitted to an inpatient palliative care unit, 45% of them were discharged, with a mean hospital staying of 15 days, and 55% died. Karnofsky status and palliative performance scale were higher for discharged patients. 19 No correlation was found between the pattern of sociodemographic variables. Moreover, the inpatient mortality was quite different from that reported in an unit like that presented in this study and previous surveys (3% to 7% of patients). 4, 5 In a study performed with a large sample of advanced cancer patients admitted to an acute palliative care unit, 958 (33%) patients died during admission, while 592 (20%), 855 (29%), 404 (14%) 56 (2%), and 33 (1%) patients were sent home, home hospice, inpatient hospice, long-term care facilities, and other institutions, respectively. Home discharge was associated with a longer survival in comparison with hospice transfers. Younger age and direct admission to the acute palliative care unit were independently associated with home discharge. 15 Data regarding the care pathway were not available, and other possible determinants of discharge, including symptom severity and Karnofsky status, were unavailable. Considering the different inpatient death rate (about 1/3), it is likely that many of these patients were severely ill in comparison with patients reported in this study. In a study including inpatients and patients seen for palliative care consultation, almost all patients were discharged to palliative care services. Stable care trajectories were found for patients with a short survival, a median of 24 days. 20 In patients with unplanned admission to an oncological unit, discharge location was influenced by a substantial physical and psychological symptom burden. However, data refers to a general oncologic ward. 21 Globally, from data of literature it seems that most palliative care units admit very advanced cancer patients with short survival and a relatively high mortality rate during admission. Thus, existing data are hard to compare with data of the present study. Despite calls for integrated palliative care, this frequently occurs late. The application of targeted cancer-specific transition points, for example an APSCU, to trigger integration of palliative care as a standard part of quality oncological care and to provide appropriate discharge disposition, are of paramount importance. 18 For these reasons, patients admitted to our APSCU may not representative of patients with cancer, and results cannot be generalizable. However, this model, that seems to deliver the earliest palliative care, should be widespread as it allows a precious weapon in the context of the concept simultaneous care. APSCU admission is not only useful for symptom control , toxicities, end of life care, but also to allow an appropriate patients' assessment according to more strict palliative care criteria and a multidisciplinary evaluation of the individual therapeutic options. In other words, APSCU may enhance coordination of care. providing a junction to choose the best pathway in terms of oncologic treatment and care setting. Another limitation is represented by the lack of information about survival. However, many patients lived at long distance from this regional center, and there was no way to gather this information.
It would be relevant to compare different models, for example external consultation or mobile teams of palliative care in oncological wards. For instance, it has been shown that APSCU allows a better planning admission to hospital and a better care trajectory in comparison to a busy oncological ward in a similar population of advanced cancer patients. 22, 23 Thus, specialized palliative care beds may facilitate the management of advanced cancer patients in the context of a busy oncological ward.
